Admission Date:  [**2106-11-26**]              Discharge Date:   [**2106-12-3**]   Service: MEDICINE  Allergies: Lipitor / Corgard  Attending:[**First Name3 (LF) 2195**] Chief Complaint: Septic Shock  Major Surgical or Invasive Procedure: ERCP IJ central line placement  History of Present Illness: 86F with hx of newly diagnosed pancreatic CA, s/p palliative CBD stent presents with persistent vomitting, diarrhea, fevers.
Upon arrival to the OSH, initial vitals 100.3 tm 104.9, 165/68 92 16 96%2L, FS 110,  the pt received a dose of Zosyn 3.375mg, KCL 20meq, 1L NS, and the pt was subsequently transferred to [**Hospital1 18**] for presumed ascending cholangitis.
The pt was noted to be hypoglycemic and subsequently received an Amp D50, KCL.
Morphine 2mg IV x1, RIJ placed.
Myopathy s/p statin 3 years ago; continues with methotrexate and prednisone taper ??????
PSYCH: Listens and responds to questions appropriately, pleasant  Pertinent Results: [**2106-11-25**] 11:45PM   WBC-25.4*# RBC-3.34* HGB-10.2* HCT-30.4* MCV-91 MCH-30.4 MCHC-33.4 RDW-15.1 [**2106-11-25**] 11:45PM   NEUTS-95* BANDS-0 LYMPHS-4* MONOS-1* EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2106-11-25**] 11:45PM   PLT SMR-NORMAL PLT COUNT-184 [**2106-11-25**] 11:45PM   PT-14.7* PTT-27.8 INR(PT)-1.3* [**2106-11-25**] 11:45PM URINE  BLOOD-MOD NITRITE-NEG PROTEIN-75 GLUCOSE-NEG KETONE-NEG BILIRUBIN-SM UROBILNGN-NEG PH-5.0 LEUK-NEG [**2106-11-25**] 11:45PM URINE  RBC-0-2 WBC-[**1-21**] BACTERIA-FEW YEAST-NONE EPI-0-2 [**2106-11-25**] 11:45PM   ALT(SGPT)-191* AST(SGOT)-120* ALK PHOS-169* TOT BILI-4.9* [**2106-11-25**] 11:45PM   LIPASE-31 [**2106-11-25**] 11:45PM   GLUCOSE-56* UREA N-29* CREAT-1.7* SODIUM-138 POTASSIUM-2.9* CHLORIDE-105 TOTAL CO2-19* ANION GAP-17 [**2106-11-25**] 11:51PM   LACTATE-2.2* [**2106-11-26**] 05:54AM BLOOD Cortsol-10.8 .
If there is concern for a pancreatic mass, CTA would be recommended.
The previously placed plastic biliary stent was removed with a snare successfully.
Cannulation of the biliary duct was performed with a sphincterotome after a guidewire was placed.
A 6cm by 10mm covered metal Wallflex (LOT# [**Serial Number 81062**]) biliary stent was placed successfully.
Discharge Day Laboratories: [**2106-12-3**] WBC-7.3 RBC-3.51* Hgb-10.2* Hct-32.3* MCV-92 Plt Ct-260 [**2106-12-3**] Glucose-58* UreaN-16 Creat-1.2* Na-142 K-3.5 Cl-103 HCO3-29  Brief Hospital Course: 86F with hx of pancreatic CA s/p biliary stenting presenting with ascending cholangitis.
Patient received IVF, but remained hypotensive so was started on Levophed.
Patient underwent ERCP with replacement of her temporary biliary stent with a permanent stent.
#: Ascending Cholangitis: Pt with elevated transaminases, Alk Phos, TB in setting of a stent 1.4cm in the CBD.
Patient received large amount NS, and hyperchloremic metabolic acidosis was also a contributor to her acid-base picture.
DDx included sepsis, decreased PO in setting of regular insulin dosing.
Patient was re-started on her home Lasix when transferred to the general medicine floor, which she tolerated well.
# Myositis: Pt was on long term steroids and methotrexate.
She was given stress dose steroids which were weaned back to her baseline of prednisone 10mg daily and she remained hemodynamically stable.
Rad onc was also consulted for potential palliative XRT in the future.
#Diarrhea: Patient complained of loose stools upon resumption of her diet after stent placement.
Patient had trace bilateral edema at the time of discharge, and was given TEDs and advised to elevate her feet and ambulate frequently.
Medications on Admission: Prednisone 10mg PO Daily Methotrexate 15mg PO Friday Aspirin 81mg PO Daily Hydrochlorothiazide 25mg PO Daily Lisinopril 20mg PO QHS Folic Acid 1mg PO Daily Fosamax 70mg PO once a week.
Insulin Glargine 100 unit/mL Solution Sig: Four (4) units Subcutaneous After breakfast.
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO DAILY (Daily).
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Prednisone 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amoxicillin-Pot Clavulanate 500-125 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 6 days: To be completed on [**2106-12-9**].
Lantus 100 unit/mL Cartridge Sig: Four (4) units Subcutaneous at bedtime.
You underwent repeat metal stenting to open the obstruction.
You were also treated with IV antibiotics, which were changed to oral antibiotics at discharge.
Please take your antibiotic as prescribed to complete a course on [**2106-12-9**].
Other than the addition of your antibiotic, no other changes were made to your home medications.
